Showing results (271-280 of 289) with videos related to
Sort By:
Pageof 29
Carcinogenesis|May 15, 2013
MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expressionKai Zhu, Qi Pan, Xin Zhang, et al.Plos One|June 7, 2013
Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinomaLu Lu, Hui-Chuan Sun, Wei Zhang, et al.Cell Death & Disease|May 9, 2020
NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinomaKang-Shuai Li, Xiao-Dong Zhu, Hong-Da Liu, et al.Journal of Hepatology|March 22, 2017
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinomaAo Huang, Xin Zhao, Xin-Rong Yang, et al.Hepatology (Baltimore, Md.)|June 19, 2012
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinomaNaoki Oishi, Mia R Kumar, Stephanie Roessler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resectionXin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.The New England Journal of Medicine|October 9, 2009
MicroRNA expression, survival, and response to interferon in liver cancerJunfang Ji, Jiong Shi, Anuradha Budhu, et al.Journal of Cancer Research and Clinical Oncology|June 16, 2010
Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resectionDan-Dan Wang, Yi-Ming Zhao, Lu Wang, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 13, 2004
Changed clinical aspects of primary liver cancer in China during the past 30 yearsBing-Hui Yang, Jing-Lin Xia, Li-Wen Huang, et al.Zhonghua Yi Xue Za Zhi|August 6, 2003
[Changes of clinical aspect of primary liver cancer in China during the past 30 years--control study for 3,250 cases with primary liver cancer]Bing-hui Yang, Jing-lin Xia, Li-wen Huang, et al.Pageof 29